Abstract
Direct measure of coenzyme Q (CoQ) in biological specimens may provide important advantages. Precise and selective high-performance liquid chromatography (HPLC) methods with electrochemical (EC) detection have been developed for the measurement of reduced (ubiquinol) and oxidized (ubiquinone) CoQ in biological fluids, cells, and tissues. EC detection is preferred for measurement of CoQ because of its high sensitivity. Reduced and oxidized CoQ are first extracted from biological specimens using 1-propanol. After centrifugation, the 1-propanol supernatant is directly injected into HPLC and monitored at a dual-electrode. The EC reactions occur at the electrode surface. The first electrode transforms ubiquinone into ubiquinol, and the second electrode measures the current produced by the oxidation of the hydroquinone group of ubiquinol. The methods described provide rapid, precise, and simple procedures for determination of reduced and oxidized CoQ in biological fluids, cells, and tissues. The methods have been successfully adapted to meet regulatory requirements for clinical laboratories, and have been proven reliable for analysis of clinical and research samples for clinical trials and animal studies involving large numbers of specimens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Turunen M., Olsson J., and Dallner G. (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660, 171–199.
Bentinger M., Tekle M., and Dallner G. (2010) Coenzyme Q-biosynthesis and functions. Biochem Biophys Res Commun. 21, 396, 74–79.
Barshop B.A. and Gangoiti J.A. (2007) Analysis of coenzyme Q in human blood and tissues. Mitochondrion 7 Suppl, S89–93.
Quinzii C.M., López L.C., Gilkerson R.W., et al. (2010) Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J. 24, 3733–3743.
Rodríguez-Hernández A., Cordero M.D., Salviati L., et al. (2009) Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy. 5, 19–32.
Miles L., Miles M.V., Tang P.H., et al. (2005) Coenzyme Q: a potential marker for mitochondrial activity and redox status in skeletal muscle. Pediatr Neurol 32, 318–324.
Miles L., Wong B.L., Dinopoulos A., et al. (2006) Investigation of children for mitochondriopathy confirms need for strict patient selection, improved morphological criteria, and better laboratory methods. Hum Pathol 37, 173–184.
Haas R.H., Parikh S., Falk M.J., et al. (2008) The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94, 16–37.
Miles M.V., Miles L., Tang P.H., et al. (2008) Systematic evaluation of muscle coenzyme Q10 content in children with mitochondrial respiratory chain deficiencies. Mitochondrion 8, 170–180.
Miles M.V., Putnam P.E., Miles L., et al. (2011) Acquired coenzyme Q10 deficiency in children with recurrent food intolerance and allergies. Mitochondrion 11, 127–135.
Quinzii C.M. and Hirano M. (2010) Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev 16, 183–188.
Quinzii C.M., López L.C., Von-Moltke J., et al. (2008) Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J 22, 1874–1885.
Villalba J.M., Parrado C., Santos-Gonzalez M., et al. (2010) Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin Investig Drugs 19, 535–554.
Tang P.H., Miles M.V., DeGrauw A., et al. (2001) HPLC analysis of reduced and oxidized coenzyme Q10 in human plasma. Clin Chem 47, 256–265.
Miles M.V., Horn P., Morrison J.A., et al. (2003) Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin Chim Acta 332, 123–132.
Miles M.V., Horn P.S., Tang P.H., et al. (2004) Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta 347, 139–144.
Niklowitz P., Andler W., and Menke T. (2006) Coenzyme Q10 concentration in plasma and blood cells: what about diurnal changes? Biofactors 28, 47–54.
Miles M.V., Tang P.H., Miles L., et al. (2008) Validation and application of an HPLC-EC method for analysis of coenzyme Q10 in blood platelets. Biomed Chromatogr 22, 1403–1408.
Tang P.H., Miles M.V., Miles L., et al. (2004) Measurement of reduced and oxidized coenzyme Q9 and coenzyme Q10 levels in mouse tissues by HPLC with coulometric detection. Clin Chim Acta 341, 173–184.
Sacconi S., Trevisson E., Salviati L., et al. (2010) Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 20, 44–48.
Tang P.H., Miles M.V., Steele P., et al. (2006) Determination of coenzyme Q10 in human breast milk by high-performance liquid chromatography. Biomed Chromatogr 20, 1336–1343.
Colomé C., Artuch R., Vilaseca M.A. et al. (2002) Ubiquinone-10 content in lymphocytes of phenylketonuric patients. Clin Biochem 35, 81–84.
Kohli R., Kirby M., Xanthakos S.A., et al. (2010) High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52, 934–944.
Isobe C., Abe T., and Terayama Y. (2010) Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci Lett 469, 159–163.
Niklowitz P., Menke T., Wiesel T., et al. (2002) Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia. Clin Chim Acta 326, 155–161.
Albano C.B., Muralikrishnan D., and Ebadi M. (2002) Distribution of coenzyme Q homologues in brain. Neurochem Res 27, 359–368.
Balercia G., Buldreghini E., Vignini A., et al. (2009) Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril 91, 1785–1792.
Diomedi-Camassei F., Di Giandomenico S., Santorelli F.M., et al. (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18, 2773–2780.
Montero R., Sánchez-Alcázar J.A., Briones P., et al. (2008) Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin Biochem 41, 697–700.
Haas D., Niklowitz P., Hörster F., et al. (2009) Coenzyme Q(10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis 32, 570–575.
DiMauro S., Quinzii C.M., and Hirano M. (2007) Mutations in coenzyme Q10 biosynthetic genes. J Clin Invest 117, 587–589.
Debray F.G., Lambert M., and Mitchell G.A. (2008) Disorders of mitochondrial function. Curr Opin Pediatr 20, 471–482.
Miles M.V., Patterson B.J., Chalfonte–Evans M., et al. (2007) Ubiquinol-10 improves oxidative imbalance in children with trisomy 21. Pediatr Neurol 37, 398–403.
Montero R., Sánchez-Alcázar J.A., Briones P., et al. (2009) Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report. Clin Biochem 42, 742–745.
Haas D., Niklowitz P., Hoffmann G.F., et al. (2008) Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors. Biofactors 32, 191–197.
Sohmiya M., Tanaka M., Tak N.W., et al. (2004) Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson’s disease. J Neurol Sci 223, 161–166.
Cooper J.M., Korlipara L.V., Hart P.E., et al. (2008) Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy. Eur J Neurol 15, 1371–1379.
Ochoa J.J., Ramirez-Tortosa M.C., Quiles J.L., et al. (2003) Oxidative stress in erythrocytes from premature and full-term infants during their first 72 h of life. Free Radic Res 3, 317–322.
Roland L., Gagné A., Bélanger M.C., et al. (2010) Existence of compensatory defense mechanisms against oxidative stress and hypertension in preeclampsia. Hypertens Pregnancy 29, 21–37.
Hershey A.D., Powers S.W., Vockell A.L., et al. (2007) Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47, 73–80.
Laguna T.A., Sontag M.K., Osberg I., et al. (2008) Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with cystic fibrosis. J Pediatr 153, 402–407.
Mancini A., Leone E., Silvestrini A., et al. (2010) Evaluation of antioxidant systems in pituitary-adrenal axis diseases. Pituitary 13, 138–145.
Bélanger M.C., Mirault M.E., Dewailly E., et al. (2008) Environmental contaminants and redox status of coenzyme Q10 and vitamin E in Inuit from Nunavik. Metabolism 57, 927–933.
Suzuki T., Nozawa T., Sobajima M., et al. (2008) Atorvastatin-induced changes in plasma coenzyme Q10 and brain natriuretic peptide in patients with coronary artery disease. Int Heart J 49, 423–433.
Niklowitz P., Wiesel T., Andler W., and Menke T. (2007) Coenzyme Q10 concentration in the plasma of children suffering from acute lymphoblastic leukemia before and during induction treatment. Biofactors 29, 83–89.
Steele P.E., Tang P.H., DeGrauw T.J., and Miles M.V. (2004) Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases. Am J Clin Pathol 121 (Suppl 1), S113–S120.
Takada M., Ikenoya S., Yuzuriha T., and Katayama K. (1984) Simultaneous determination of reduced and oxidized ubiquinones. Methods Enzymol 105, 147–155.
Lang J.K. and Packer L. (1987) Quantitative determination of vitamin E and oxidized and reduced coenzyme Q by high-performance liquid chromatography with in-line ultraviolet and electrochemical detection. J Chromatogr 385, 109–117.
Edlund P.O. (1988) Determination of coenzyme Q10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 425, 87–97.
Okamoto T., Fukunaga Y., Ida Y., and Kishi T. (1988) Determination of reduced and total ubiquinones in biological materials by liquid chromatography with electrochemical detection. J Chromatogr 430, 11–19.
Grossi G., Bargossi A.M., Fiorella P.L., and Piazzi S. (1992) Improved high-performance liquid chromatographic method for the determination of coenzyme Q10 in plasma. J Chromatogr 593, 217–226.
Wakabayashi H., Yamato S., Nakajima M., and Shimada K. (1994) Simultaneous determination of oxidized and reduced coenzyme Q and alpha-tocopherol in biological samples by high performance liquid chromatography with platinum catalyst reduction and electrochemical detection. Biol Pharm Bull 17, 997–1002.
Finckh B., Kontush A., Commentz J., et al. (1995) Monitoring of ubiquinol-10, ubiquinone-10, carotenoids, and tocopherols in neonatal plasma microsamples using high-performance liquid chromatography with coulometric electrochemical detection. Anal Biochem 232, 210–216.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Tang, P.H., Miles, M.V. (2012). Measurement of Oxidized and Reduced Coenzyme Q in Biological Fluids, Cells, and Tissues: An HPLC-EC Method. In: Wong, Ph.D., LJ. (eds) Mitochondrial Disorders. Methods in Molecular Biology, vol 837. Humana Press. https://doi.org/10.1007/978-1-61779-504-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-61779-504-6_10
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-503-9
Online ISBN: 978-1-61779-504-6
eBook Packages: Springer Protocols